Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

PCOS has no cure, but treatments can manage symptoms and improve health.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Women with acne have lower levels of a specific hormone marker than women without acne.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.